What is the recommended dose and duration of Augmentin (amoxicillin/clavulanate) for a patient with a urinary tract infection (UTI) and potential impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dosing for UTI in Patients with Impaired Renal Function

For patients with UTI and impaired renal function, Augmentin (amoxicillin/clavulanate) should be dosed at 500 mg/125 mg every 12 hours or 250 mg/125 mg every 24 hours, depending on the severity of renal impairment and infection. 1, 2

Dosing Based on Renal Function

Normal to Moderate Renal Impairment

  • For patients with normal renal function or mild impairment (GFR >30 mL/min):
    • 500 mg/125 mg every 12 hours for mild/moderate infections 1, 2
    • 875 mg/125 mg every 12 hours for severe infections 1, 2

Severe Renal Impairment

  • For patients with GFR 10-30 mL/min:
    • 500 mg/125 mg or 250 mg/125 mg every 12 hours, depending on infection severity 1, 2
  • For patients with GFR <10 mL/min:
    • 500 mg/125 mg or 250 mg/125 mg every 24 hours, depending on infection severity 1, 2
  • Patients on hemodialysis:
    • 500 mg/125 mg or 250 mg/125 mg every 24 hours 2
    • Additional dose should be administered both during and at the end of dialysis 1, 2

Duration of Treatment

  • Standard duration for UTI treatment is 7 days 3
  • Treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic 1
  • For complicated UTIs or in patients with impaired renal function, a 10-day course may be appropriate to ensure complete bacterial eradication 3, 4

Administration Guidelines

  • Augmentin should be taken at the start of a meal to enhance absorption of clavulanic acid and minimize gastrointestinal intolerance 2
  • For patients unable to swallow tablets, oral suspension can be prepared according to package instructions 1

Special Considerations for Renal Patients

  • Patients with severely impaired renal function (GFR <30 mL/min) should NOT receive the 875 mg/125 mg formulation 1, 2
  • Monitoring of renal function is recommended during treatment 5
  • Hepatically impaired patients should be dosed with caution and hepatic function monitored at regular intervals 2

Clinical Efficacy in UTI

  • Augmentin has demonstrated success rates of approximately 70% for amoxicillin-resistant organisms in UTIs 6
  • For recurrent UTIs, clinical studies have shown microbiological cure rates of 84% one week after treatment and 67% one month later 3

Potential Side Effects and Monitoring

  • Monitor for gastrointestinal side effects, which occur in approximately 20% of patients but are generally mild 3
  • In patients with renal impairment, monitor for signs of drug accumulation 7
  • Consider baseline and periodic assessment of renal and hepatic function during treatment 5

Pitfalls to Avoid

  • Avoid excessive accumulation of the drug by adhering to recommended dosing intervals based on renal function 5
  • Do not substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet, as they contain different ratios of amoxicillin to clavulanic acid 2
  • Patients on hemodialysis require supplemental dosing during and after dialysis sessions to maintain therapeutic levels 2, 7

Remember that proper dosing of Augmentin in patients with impaired renal function is essential to balance efficacy against the risk of drug accumulation and toxicity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.